Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study

BACKGROUND: Myelodysplastic syndromes (MDS) are characterized by ineffective erythropoiesis with dysplastic bone marrow leading to peripheral cytopenia, risk of infection, and progression to acute myelogenous leukemia. Maitake mushroom beta-glucan, a dietary supplement, stimulates hematopoietic prog...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Immunol Immunother
Autors principals: Wesa, Kathleen M., Cunningham-Rundles, Susanna, Klimek, Virginia M., Vertosick, Emily, Coleton, Marci I., Yeung, K. Simon, Lin, Hong, Nimer, Stephen, Cassileth, Barrie R.
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2014
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4317517/
https://ncbi.nlm.nih.gov/pubmed/25351719
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-014-1628-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars